ESPE2016 Working Groups ESPE Diabetes Technology and Therapeutics Working Group (7 abstracts)
Bournemouth, UK
Background: Research has demonstrated that technologies to support diabetes self-management for people living with diabetes can have positive effects on medical and quality of life outcomes. It also shows that there may be an additional burden of wearing and using these technologies. Both diabetes and its treatment can have significant deleterious effect on quality of life, thus it is crucial that the interaction between the technology and the user offers maximum benefit with minimum burden.
Objective and hypotheses: Dr Barnards talk explores the rapidly changing world of diabetes technology and its impact on the lives of people living with diabetes. She will discuss the role of healthcare professionals in supporting appropriate use of technology, both in terms of access and what success looks like to different key stakeholders.
Method: An overview of recent technological developments including automated insulin delivery systems, continuous glucose monitoring and so-called smart meters. Specific focus on the benefits and burdens of technologies, in the context of everyday living, and how to effectively manage expectations to ensure optimal outcomes both bio-medically and psychosocially.
Results: Delegates will be guided through the minefield that is diabetes technology, its uptake and continued successful use for people with diabetes.